CTRI Number |
CTRI/2025/05/086471 [Registered on: 07/05/2025] Trial Registered Prospectively |
Last Modified On: |
06/05/2025 |
Post Graduate Thesis |
No |
Type of Trial |
Observational |
Type of Study
|
Correlation study |
Study Design |
Other |
Public Title of Study
|
FRAILTY,FALL RISK AND PROTEIN ENERGY WASTING IN HEMODIALYSIS PATIENTS |
Scientific Title of Study
|
RELATIONSHIP BETWEEN THE FRAILTY,FALL RISK AND PROTEIN ENERGY WASTING AMONG HEMODIALYSIS PATIENTS |
Trial Acronym |
Not applicable |
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
NANCY EMELDA S |
Designation |
UG STUDENT |
Affiliation |
SRM INSTITUTE OF SCIENCE AND TECHNOLOGY |
Address |
ROOM NO-PT 13,5TH FLOOR,SRM COLLEGE OF PHYSIOTHERAPY,SRM INSTITUTE OF SCIENCE AND TECHNOLOGY,KATTANKULATHUR,CHENGALPATTU,TAMILNADU
Kancheepuram TAMIL NADU 603203 India |
Phone |
7708579541 |
Fax |
|
Email |
ns4732@srmist.edu.in |
|
Details of Contact Person Scientific Query
|
Name |
KAVIYA M |
Designation |
ASSISTANT PROFESSOR |
Affiliation |
SRM INSTITUTE OF SCIENCE AND TECHNOLOGY |
Address |
5TH FLOOR,SRM COLLEGE OF PHYSIOTHERAPY,SRM INSTITUTE OF SCIENCE&TECHNOLOGY,KATTANKULATHUR,CHENGALPATTU,TAMILNADU
Kancheepuram TAMIL NADU 603203 India |
Phone |
9940513772 |
Fax |
|
Email |
kaviyam3@srmist.edu.in |
|
Details of Contact Person Public Query
|
Name |
KAVIYA M |
Designation |
ASSISTANT PROFESSOR |
Affiliation |
SRM INSTITUTE OF SCIENCE AND TECHNOLOGY |
Address |
ROOM NO- ,5TH FLOOR, SRM COLLEGE OF PHYSIOTHERAPY,SRM INSTITUTE OF SCIENCE AND TECHNOLOGY,KATTANKULATHUR,CHENGALPATTU,TAMILNADU.
Kancheepuram TAMIL NADU 603203 India |
Phone |
9940513772 |
Fax |
|
Email |
kaviyam3@srmist.edu.in |
|
Source of Monetary or Material Support
|
SRM College of Physiotherapy,SRMIST,Kattankulathur,TAMILNADU,INDIA 603203 |
|
Primary Sponsor
|
Name |
NANCY EMELDA S |
Address |
ROOM NO-PT 13,5TH FLOOR,SRM COLLEGE OF PHYSIOTHERAPY,SRM INSTITUTE OF SCIENCE &TECHNOLOGY,KATTANKULATHUR,CHENGALPATTU,TAMILNADU |
Type of Sponsor |
Other [SELF FUNDED] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr KAVIYA M |
SRM MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE |
ROOM NO:4,5TH FLOOR,RENAL DIALYSIS CENTRE,SRM MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE,KATTANKULATHUR,CHENGALPATTU,TAMILNADU. Kancheepuram TAMIL NADU |
9940513772
kaviyam3@srmist.edu.in |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
SRM MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: N19||Unspecified kidney failure, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
NOT APPLICABLE |
NOT APPLICABLE |
Comparator Agent |
NOT APPLICABLE |
NOT APPLICABLE |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
80.00 Year(s) |
Gender |
Both |
Details |
The patients with chronic kidney disease(CKD),The male and female above 18 years,Patients undergoing haemodialysis for more than 3 months,
The patient who have ability to understand the informed consent and sign it,Ambulating patients.
|
|
ExclusionCriteria |
Details |
Patients with any cognitive Impairment,
Patients whose recent medical records are unavailable,
Patients with disabilities other than CKD (Amputations, other balance disorders due to neurological impairment),
Patients involved in other clinical trials receiving experimental treatments that may affect outcomes,
Renal transplanted patients,
Patient undergoing peritoneal dialysis,
Any active Neoplastic or infectious disease.
|
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
TO INVESTIGATE THE RELATIONSHIP BETWEEN THE FRAILTY,FALL RISK AND PROTEIN ENERGY WASTING(PEW) IN HEMODIALYSIS PATIENTS |
8-12 weeks |
|
Secondary Outcome
|
Outcome |
TimePoints |
TO EXPLORE THE ASSOCIATION OF DEMOGRAPHIC AND CLINICAL FACTORS SUCH AS AGE,GENDER,COMORBIDITIES WITH FRAILTY,FALL RISK AND PROTEIN ENERGY WASTING(PEW). |
8-12 weeks |
|
Target Sample Size
|
Total Sample Size="111" Sample Size from India="111"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
17/05/2025 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="0" Months="3" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
N/A |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
The study will be proceeded after getting approval from the institutional ethical committee (IEC).Patients will be selected based on the inclusion and exclusion criteria .Informed consent will be obtained from the patients to ensure their willingness in this study.The need for the study will be clearly explained to the patients in their Regional language.The frailty will be assessed from the participants by asking the questions form the Edmonton frailty scale which is administered by the researcher.The person who’s score ranges from 8 to 17 is considered frail.The protein energy wasting will be assessed using the subjective global assessment.The nutritional status of the individual participants can be taken from the medical records.The fall risks for the CKD patients will be assessed using the fall risk assessment tool. |